Authors:
SHOU M
LU T
MEI Q
RUSHMORE T
BAILLIE TA
GONZALEZ FJ
GELBOIN HV
Citation: M. Shou et al., USING MONOCLONAL-ANTIBODIES TO ASSESS THE CONTRIBUTION OF INDIVIDUAL CYTOCHROME P450S TO DRUG-METABOLISM IN HUMAN LIVER, The FASEB journal, 12(4), 1998, pp. 847-847
Authors:
SAI Y
DAI R
YANG T
RUSHMORE T
BAILLIE TA
GONZALEZ FJ
GELBOIN HV
SHOU M
Citation: Y. Sai et al., INHIBITION-KINETICS OF MONOCLONAL-ANTIBODIES AGAINST CYTOCHROME P450-MEDIATED DRUG-METABOLISM, The FASEB journal, 12(4), 1998, pp. 848-848
Authors:
SILVA JM
MORIN PE
DAY SH
KENNEDY BP
PAYETTE P
RUSHMORE T
YERGEY JA
NICOLLGRIFFITH DA
Citation: Jm. Silva et al., REFINEMENT OF AN IN-VITRO CELL MODEL FOR CYTOCHROME-P450 INDUCTION, Drug metabolism and disposition, 26(5), 1998, pp. 490-496
Authors:
SPIELBERG S
MCCREA J
CRIBB A
RUSHMORE T
WALDMAN S
BJORNSSON T
LO MW
GOLDBERG M
Citation: S. Spielberg et al., A MUTATION IN CYP2C9 IS RESPONSIBLE FOR DECREASED METABOLISM OF LOSARTAN, Clinical pharmacology and therapeutics, 59(2), 1996, p.
Citation: T. Nguyen et al., TRANSCRIPTION REGULATION OF GLUTATHIONE-S-TRANSFERASE GENE-EXPRESSIONBY OXIDATIVE STRESS, Journal of cellular biochemistry, 1995, pp. 238-238